Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines

NCT06267924 is registered in ClinicalTrials.gov with Otolith Labs as lead sponsor.

NCT NCT06267924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06267924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines
Lead sponsor
Otolith Labs
Phase
Not applicable
Overall status
Completed
Start date
March 6, 2024
Completion date
January 8, 2025
Enrollment
322 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine associated vertigo, vestibular migraine